German chronic cohort (n = 147) | US ALF cohort (n = 28) | |
---|---|---|
Age at blood sample collection (years) | 35 (16–69) | 26 (15–57) |
Female gender | 79 (54%) | 20 (71%) |
ALT (U/L) | 36 (10–436) | 36 (7–1463) |
AST (U/L) | 30 (8–580) | 188 (43–4481) |
GGT (U/L) | 33 (5–471) | – |
Bilirubin (mg/dL) | 0.7 (0.3–7.8) | 31.4 (4.5–67.6) |
Albumin (g/L) | 44 (22–53) | 24 (16–28) |
Urea (kU/L) | 6.1 (1.0–11.9) | – |
Sodium (mmol/L) | – | 139 (131–149) |
Creatinine (mg/dL) | 0.7 (0.4–2.4) | 1.2 (0.4–7.1) |
WBC count (× 109/L) | 5.9 (2.5–12.8) | 13.4 (3.4–54.9) |
INR | 1.1 (0.9–2.0) | 2.8 (1.7–6.5) |
Phosphate (mmol/dL) | – | 2.9 (1.0–11.7) |
Serum copper (μmol/L)† | 4.5 (0.1–29.9) | 0.3 (0.2–208.0) |
Ceruloplasmin (g/L) | 0.10 (0.01–0.32) | 0.17 (0.04–0.45) |
Urinary copper (μmol/day)†, ‡ | 2.5 (0.2–27.5) | 40,110.2 (661.4–9,931,842.2) |